Your browser doesn't support javascript.
Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome.
Okour, Malek; Al-Kofahi, Mahmoud; Austin, Daren.
  • Okour M; GlaxoSmithKline, Collegeville, PA, USA. malek.x.okour@gsk.com.
  • Al-Kofahi M; College of Pharmacy, University of Minnesota, Minneapolis, MN, USA.
  • Austin D; GlaxoSmithKline, London, UK.
J Pharmacokinet Pharmacodyn ; 47(3): 187-188, 2020 06.
Article in English | MEDLINE | ID: covidwho-266547

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Azithromycin / Hydroxychloroquine Type of study: Diagnostic study / Experimental Studies / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: J Pharmacokinet Pharmacodyn Journal subject: Pharmacology Year: 2020 Document Type: Article Affiliation country: S10928-020-09689-x

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Azithromycin / Hydroxychloroquine Type of study: Diagnostic study / Experimental Studies / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: J Pharmacokinet Pharmacodyn Journal subject: Pharmacology Year: 2020 Document Type: Article Affiliation country: S10928-020-09689-x